Ultrastructural markers of quality in human mature oocytes vitrified using cryoleaf and cryoloop.
This study describes and compares the possible effects of vitrification on the ultrastructural morphology of 20 human mature oocytes vitrified using two different supports, cryoleaf (n = 10) and cryoloop (n = 10). Fresh human mature oocytes (n = 15) were used as controls. Fresh and vitrified-warmed oocytes appeared rounded, with a homogeneous cytoplasm, an intact oolemma and a continuous zona pellucida. Sparse microvacuolization was only occasionally detected in fresh and vitrified-warmed oocytes, to the same extent. About 50% of the vitrified oocytes contained atypical, small and slender mitochondria-smooth endoplasmic reticulum aggregates, whereas a non-homogeneous microvillar pattern was observable in only 30% of the oocytes subjected to vitrification, regardless of the support utilized. Cortical granule content appeared generally reduced after vitrification, but cryoleaf-supported oocytes contained more cortical granules than cryoloop-supported oocytes (P < 0.05). Thus good overall preservation and virtual absence of cytoplasmic vacuolization seem to be the most relevant markers of quality in vitrified-warmed oocytes, using either support. In addition, cryoleaf-supported oocytes retained a higher number of cortical granules than cryoloop-supported oocytes. The variety of ultrastructural alterations recorded emphasizes the need for further studies aimed at assessing the actual tolerance of human oocytes to vitrification.
Nottola
S A
SA
Department of Anatomy, Sapienza University, Rome 00161, Italy. stefania.nottola@uniroma1.it
Coticchio
G
G
Sciajno
R
R
Gambardella
A
A
Maione
M
M
Scaravelli
G
G
Bianchi
S
S
Macchiarelli
G
G
Borini
A
A
D015415:Biomarkers; D002462:Cell Membrane / Q000187:drug effects / Q000648:ultrastructure*; D015925:Cryopreservation / Q000379:methods*; D003451:Cryoprotective Agents / Q000494:pharmacology; D005615:Freezing; D006801:Humans; D046529:Microscopy, Electron, Transmission; D009865:Oocytes / Q000187:drug effects / Q000648:ultrastructure*; D014617:Vacuoles / Q000187:drug effects / Q000648:ultrastructure*; D015044:Zona Pellucida / Q000187:drug effects / Q000648:ultrastructure
D015415:Biomarkers; D003451:Cryoprotective Agents